Is Hinge Health, Inc. (NYSE:HNGE) a buy in 2026?
Yes, on balance. The Compass leans toward accumulating Hinge Health, Inc. at current levels.
The first digital MSK platform to prove enterprise health-tech can compound at scale, with the AI care model still underestimated.
Where HNGE is headed
Hinge Health enters 2028 as the default musculoskeletal care layer inside the American self-insured employer, and that is a bigger prize than the market has admitted. Roughly one in three healthcare dollars spent by large employers touches an MSK claim somewhere, from a weekend rotator cuff to a $90,000 spinal fusion. Hinge sits at the front door of that spend with a product that costs the employer a fraction of a single surgery and increasingly resolves the issue before it hits a claims report. Revenue running north of $1.4B by FY27 on 40%+ growth, gross margins already at 84.5%, and free cash flow of $299M on a $7.2B market cap is not a speculative digital health story anymore. It is a real software business masquerading as a healthcare company, and the multiple has not caught up to that recognition.
Read the full Compass Direction on HNGE
The complete destination call, the overlooked angle, milestones, and bull, base, and bear price scenarios (around $89.33).
See the full HNGE analysisGet calls like this, free
Join the Alexandria e-letter for forward-looking verdicts, earnings intelligence, and the contrarian reads the crowd misses. Twice a week, no noise.
Free forever. Unsubscribe anytime. We never share your email.
Frequently asked questions
Is Hinge Health, Inc. (NYSE:HNGE) a buy in 2026?
Yes, on balance. The Compass leans toward accumulating Hinge Health, Inc. at current levels. The first digital MSK platform to prove enterprise health-tech can compound at scale, with the AI care model still underestimated.
What is HNGE's Compass Score?
Hinge Health, Inc. scores 77/100 on Alexandria's Compass, placing it in the "Favorable" tier. Scores blend eight factors and update weekly.
What is the price target for HNGE?
Alexandria's full Compass Direction includes bull, base, and bear price scenarios with the valuation math behind each. Read the full breakdown on the HNGE page.
Compass verdicts are AI-generated, forward-looking editorial research from publicly available data, not investment advice or a recommendation regarding any security. Scores and verdicts update as the data changes.